HALO - HALOZYME THERAPEUTICS, INC.

67.36
-2.660   -3.949%

Share volume: 1,840,308
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$70.02
-2.66
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-06-2024 10-31-2024 02-18-2025 05-06-2025 08-05-2025 11-03-2025 02-17-2026
Cash flow financing -489.000 K 9.482 M 18.561 M -246.415 M -3.321 M -298.966 M -22.402 M 239.515 M
Other financing cash flows -489.000 K 0.000 0.000 0.000 -3.321 M 0.000 0.000 0.000
Cash flow 46.257 M 23.237 M -33.546 M -38.468 M 60.478 M -114.467 M 357.804 M -283.244 M
Net income 76.823 M 93.245 M 137.011 M 137.012 M 118.095 M 165.160 M 175.225 M -141.591 M
Depreciation 2.443 M 2.569 M 2.598 M 2.653 M 2.687 M 2.740 M 2.658 M 3.304 M
Changes in inventories 40.233 M 0.000 0.000 0.000 586.000 K 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -82.681 M -42.039 M -167.483 M 29.480 M -90.422 M 84.788 M 201.609 M -741.788 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 3.545 M 2.582 M 1.517 M 3.052 M 950.000 K 1.563 M 3.030 M 1.427 M
Cash Change 46.257 M 23.237 M -33.546 M -38.468 M 60.478 M -114.467 M 357.804 M -283.244 M